Traphagen Investment Advisors LLC Gilead Sciences, Inc. Transaction History

Traphagen Investment Advisors LLC

  • $938 Billion
  • Q1 2024

A detailed history of Traphagen Investment Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 3,034 shares of GILD stock, worth $207,525. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,034
Holding current value
$207,525
% of portfolio
0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$71.58 - $87.29 $217,173 - $264,837
3,034 New
3,034 $222 Million
Q4 2023

Jun 17, 2024
SELL
$73.27 - $83.09 $13,335 - $15,122
-182 Reduced 6.0%
2,852 $231 Million
Q3 2023

Jun 17, 2024
SELL
$73.94 - $80.67 $13,531 - $14,762
-183 Reduced 6.03%
2,851 $214 Million
Q2 2023

Jun 17, 2024
SELL
$76.01 - $86.7 $13,909 - $15,866
-183 Reduced 6.03%
2,851 $220 Million
Q4 2022

Jun 17, 2024
SELL
$62.32 - $89.47 $11,466 - $16,462
-184 Reduced 6.06%
2,850 $245 Million
Q3 2022

Jun 17, 2024
BUY
$59.54 - $68.01 $8.02 Million - $9.16 Million
134,661 Added 52.06%
393,346 $17 Billion
Q2 2022

Jun 17, 2024
BUY
$57.72 - $65.01 $14.8 Million - $16.6 Million
255,651 Added 8426.2%
258,685 $11.9 Billion
Q1 2022

Jun 17, 2024
SELL
$57.92 - $72.58 $2.08 Million - $2.6 Million
-35,851 Reduced 25.1%
106,972 $5.33 Billion
Q4 2021

Jun 17, 2024
BUY
$64.88 - $73.64 $9.07 Million - $10.3 Million
139,789 Added 4607.42%
142,823 $7.78 Billion
Q3 2021

Jun 17, 2024
BUY
$67.69 - $73.03 $214,712 - $231,651
3,172 Added 1.98%
163,084 $8.91 Billion
Q2 2021

Jun 17, 2024
BUY
$63.47 - $69.35 $838,882 - $916,598
13,217 Added 9.01%
159,912 $8.81 Billion
Q1 2021

Jun 17, 2024
BUY
$60.0 - $68.46 $8.62 Million - $9.84 Million
143,661 Added 4735.04%
146,695 $7.83 Billion
Q4 2020

Jun 17, 2024
BUY
$56.65 - $64.55 $972,737 - $1.11 Million
17,171 Added 8.87%
210,727 $11.9 Billion
Q3 2020

Jun 17, 2024
BUY
$62.1 - $78.08 $11.8 Million - $14.9 Million
190,577 Added 6397.35%
193,556 $10.7 Billion
Q2 2020

Jun 17, 2024
SELL
$72.34 - $84.0 $3,978 - $4,620
-55 Reduced 1.81%
2,979 $229 Million
Q1 2020

Jun 17, 2024
SELL
$62.63 - $80.22 $3,507 - $4,492
-56 Reduced 1.85%
2,978 $223 Million
Q2 2019

Jun 17, 2024
BUY
$61.87 - $69.38 $2,165 - $2,428
35 Added 1.15%
3,069 $207 Million

Others Institutions Holding GILD

# of Institutions
1,885
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $85.7B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Traphagen Investment Advisors LLC Portfolio

Follow Traphagen Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email